University of California San Francisco
Give to UCSF
A drug once taken by people with HIV/AIDS, but long ago shelved after newer, modern antiretroviral therapies became available, has now shed light on how the human body uses its natural immunity to fight the virus — work that could help uncover new targets for drugs.
<p>Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.</p>
Men and women had starkly different immune system responses to chronic post-traumatic stress disorder, with men showing no response and women showing a strong response, in two studies by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
<em>The Lancet</em> launched a special series on malaria elimination Oct. 29, led by the Global Health Group (GHG), a part of UCSF Global Health Sciences. The series included work by 36 authors worldwide, with guidance and support provided by a GHG-convened global advisory group of malaria experts, known as the Malaria Elimination Group.
The heavy burden of hunger in the United States helps explain why the poor are at higher risk for obesity, high blood pressure and diabetes, according to an editorial in the July 1 <i>New England Journal of Medicine</i> co-authored by two UCSF faculty members.
An international study published in the March 25 <em>New England Journal of Medicine</em> showed what researchers call a clinical breakthrough in one of the greatest unmet needs for patients with advanced liver disease.
Narcolepsy, a sleep disorder that can cause sufferers to suddenly lose muscle tone and start dreaming, is an autoimmune disease, a team led by UCSF and Stanford scientists finds.